In: Accounting
Camden Biotechnology began operations in September 2018. The
following selected transactions relate to liabilities of the
company for September 2018 through March 2019. Camden’s fiscal year
ends on December 31. Its financial statements are issued in
April.
2018
2019
Required:
1. Prepare the appropriate journal entries for
2018 and 2019 transactions.
2. Prepare the current and long-term liability
sections of the December 31, 2018, balance sheet. Trade accounts
payable on that date were $302,000.
Part 1
Transaction | General Journal | Debit | Credit |
2018 | |||
a | no journal entry required | 0 | |
No journal entry required | 0 | ||
b | cash | 22000000 | |
Notes Payable | 22000000 | ||
C | cash | 4200 | |
Liability - refundable deposits | 4200 | ||
D | accounts receivable | 4907800 | |
Sales revenue | 4630000 | ||
Sales taxes payable (4630000*6%) | 277800 | ||
E | interest expense (22000000*9%*3/12) | 495000 | |
Interest payable | 495000 | ||
2019 | |||
F | cash | 20000000 | |
Bonds payable | 20000000 | ||
Notes Payable | 22000000 | ||
Interest expense (22000000*9%*2/12) | 330000 | ||
Interest payable | 495000 | ||
Cash | 22825000 | ||
G | liability - refundable deposits | 2100 | |
Cash (4200/2) | 2100 |
Part 2
Balance sheet
At December 31 2018
Current liabilities : | |
Sales taxes payable | 277800 |
Accrued interest payable | 495000 |
Current Portion of bank loan (22000000-20000000) | 2000000 |
Liability - refundable deposits | 4200 |
Accounts payable | 302000 |
Total current liabilities | 3074800 |
Long-term liabilities: | |
Bank loan to be refinanced | 20000000 |